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SHORT COMMUNICATION
ABSTRACT
Five species of edible mushrooms, Lentinula edodes, Pleurotus ostreatus, Pholiota nameko, Macrolepiota
bonaerensis and Agaricus blazei, were tested for their potential to inhibit the in vitro growth of the pathogenic
yeast Candida albicans. Only L. edodes had a fungistatic effect on this human pathogen. The inhibitory
compound was produced intra and extracellularly in submersed L. edodes culture, and was also present in
fresh and dehydrated mushroom basidiocarps. The fungistatic compound was heat sensitive and lost activity
after 72 hours.
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Agaricus blazei Murill on C. albicans. Mycelia from each
species was obtained by tissue culture from basidiocarps
and kept in PDA medium (Potato Dextrose Agar). Discs of
mycelia were transferred to potato broth and after 30 days
growth at 25ºC the mycelial growth substrate was obtained.
An aliquot of 0.5 ml of this substrate was added to tubes
containing 5 ml of potato broth added to a suspension of 108
cells ml-1 of C. albicans (strain 577) (the cells were obtained
by culture in potato broth for 24 hours at 25ºC and washed
three times in PBS by centrifuge). At 0, 24, 48 and 72 hours at
25ºC the number of C. albicans cells was estimated in a
Newbauer chamber and compared with the control (yeast
grown in the medium without the mycelial growth substrate).
Under these conditions, only the L. edodes mycelium,
popularly known as shiitake, showed inhibitory action on C.
albicans multiplication. The minimum dose of the mycelial
growth substrate capable of inhibiting the multiplication of
the C. albicans cells after 24, 48 and 72 hours of exposure
was 4%, 6% and 10%, respectively (Table 1). The inhibitory
agent is probably volatile or can be degraded or metabolized
Candida albicans is a yeast present in the human
gastrointestinal and genital-urinary tracts, and is very
frequent among the infections caused by fungi in
immunedepressed individuals, diabetics, and HIV carriers.
In cases of endocrinopathies such as hypothireoidism,
hypoadrenalism, and diabets, there is an increase in the
predisposition to candidiasis attributed to the increase in
glycemia and immune deficiency, which often hinders
treatment (6). The incidence of candidas also increases
during pregnancy due to an increase in the concentration of
glycogen by cells in the vaginal mucous tissues, causing
disconfort to the patient (7). Extensive clinical studies,
primarily in Japan, have clearly demonstrated that a number
of mushroom species have medicinal and therapeutic value,
in the prevention and treatment of tumors, viral and bacterial
diseases, hypercholesterolemia and blood platelet
aggregation (1,2,4).
In this preliminary report we tested the antagonic potential
of edible mushroom species Lentinula edodes, Pleurotus
ostreatus, Pholiota nameko, Macrolepiota bonaerensis, and
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during the yeast growth period. When daily doses of L.
edodes growth substrate (0.5 ml every 24 hours) were added
to the C. albicans culture, the number of cells remained
constant and lower than 104 units ml-1 of suspension, even
after 72 hours incubation, showing the fungistatic effect of L.
edodes on C. albicans. This fact prompted us to examine
whether this antibiotic effect is kept in the mushroom in the
form as it is consumed by man, fresh or dehydrated. Emerged
basidiocarps from eucalyptus (Eucaliptus saligna) logs were
used fresh and dehydrated. For dehydration, fresh mushrooms
were placed in a dehydration chamber to 60ºC until complete
water loss. The dehydrated mushroom was ground to a fine
powder and placed in infusion at the proportion of 6g: 10ml
distilled water. The fresh mushrooms were macerated in
distilled water (60g/150 ml). Part of this maceration was heated
to 100ºC for 10 minutes and the other part used fresh. The
preparations were filtered in Watmann filter paper and in
Millipore 0.45 mm and 0.22 µm and applied to the C. albicans
culture at different doses (0, 10, 15, 20 and 30%). The number
of yeast cells was estimated in a Newbauer chamber after 0, 8,
12, 24 and 48h. After 24 hours, it was possible to observe the
fresh L. edodes basidiocarp inhibitory effect, but after 48 hours
of exposure to the inhibitory agent the cells returned to growth,
confirming the fungistatic effect shown in Fig. 1. The same
was observed when the powder of dehydrated mushroom was
tested (Fig. 2).
Heat-treatment of the filtrate inactivated the inhibitory
agent. Ishikawa (3) studied the inhibitory activity of L. edodes
on Bacillus, Listeria, Staphylococcus, Acinetobacter,
Citrobacter, Enterobacter, Escherichia, Klebsiella,
Proteus, Pseudomonas, Salmonella, Serratia, Shigella
and Yersinia, observing that the greatest activity was on
Gram positive bacteria, as also observed by Komemushi et
al. (5). However, this antimicrobial compound was shown
to be heat stable, unlike the compound described in this
study.
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Table 1. Inhibition of C. albicans multiplication in potato broth
medium in presence of different concentrations of L. edodes
mycelial extract (pH 6.8).
* means followed by same letters in the vertical don’t differ
significantly for Tukey’s test (p ≤ 0.05). 0
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Figure 2. Effect of different doses of the dehidrated extract of
L. edodes basidiocarps on growth of Candida albicans.
Figure 1. Effect of different doses of Lenticula edodes mycelial
substrate on growth of Candida albicans.
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In conclusion, the findings of this study have shown that L.
edodes produces a fungistatic agent, which is able to control C.
albicans multiplication. The agent is present both in the
basidiocarps and in the mycelia, which is secreted in the growth
medium. This substance is heat sensitive and looses activity
after 72 hours.178
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RESUMO
Efeito antagonístico de extratos de cogumelos
comestíveis sobre Candida albicans
Cinco espécies de cogumelos comestíveis, Lentinula edodes,
Pleurotus ostreatus, Pholiota nameko, Macrolepiota
bonaerensis e Agaricus blazei foram avaliadas quanto ao seu
potencial em inibir o crescimento “in vitro” da levedura patogênica
Candida albicans. Apenas a espécie L. edodes apresentou efeito
fungistático sobre este patógeno humano. O composto inibitório
foi produzido intra e extracelularmente em cultivo submerso de
L. edodes e também estava presente em basidiocarpos frescos
e desidratados do cogumelo. O composto fungistático é
termossensível e perde sua atividade após 72 horas.
Palavras-chave: cogumelos, antibióticos, candidíase, efeito
fungistático
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